Comprehensive mapping of immune perturbations associated with severe COVID-19

Leticia Kuri-Cervantes(University of Pennsylvania), M. Betina Pampena(University of Pennsylvania), Wenzhao Meng, Aaron M. Rosenfeld, C.A.G. Ittner(Translational Therapeutics (United States)), Ariel R. Weisman(Translational Therapeutics (United States)), R.S. Agyekum(Translational Therapeutics (United States)), Divij Mathew(Translational Therapeutics (United States)), Amy E. Baxter(Translational Therapeutics (United States)), Laura A. Vella(Children's Hospital of Philadelphia), Oliva Kuthuru(Translational Therapeutics (United States)), Sokratis A. Apostolidis(Hospital of the University of Pennsylvania), Luanne Bershaw(Translational Therapeutics (United States)), Jeanette Dougherty(Translational Therapeutics (United States)), Allison R. Greenplate(Translational Therapeutics (United States)), Ajinkya Pattekar(Hospital of the University of Pennsylvania), Justin Kim(Translational Therapeutics (United States)), Nicholas Han(Translational Therapeutics (United States)), Sigrid Gouma(University of Pennsylvania), Madison E. Weirick(University of Pennsylvania), Claudia P. Arevalo(University of Pennsylvania), Marcus J. Bolton(University of Pennsylvania), Eileen C. Goodwin(University of Pennsylvania), Elizabeth M. Anderson(University of Pennsylvania), Scott E. Hensley(University of Pennsylvania), Tiffanie K. Jones(Translational Therapeutics (United States)), Nilam S. Mangalmurti(Translational Therapeutics (United States)), Eline T. Luning Prak, E. John Wherry(Parker Institute for Cancer Immunotherapy), Nuala J. Meyer(Translational Therapeutics (United States)), Michael R. Betts(University of Pennsylvania)
Science Immunology
July 3, 2020
Cited by 801Open Access
Full Text

Abstract

Although critical illness has been associated with SARS-CoV-2-induced hyperinflammation, the immune correlates of severe COVID-19 remain unclear. Here, we comprehensively analyzed peripheral blood immune perturbations in 42 SARS-CoV-2 infected and recovered individuals. We identified extensive induction and activation of multiple immune lineages, including T cell activation, oligoclonal plasmablast expansion, and Fc and trafficking receptor modulation on innate lymphocytes and granulocytes, that distinguished severe COVID-19 cases from healthy donors or SARS-CoV-2-recovered or moderate severity patients. We found the neutrophil to lymphocyte ratio to be a prognostic biomarker of disease severity and organ failure. Our findings demonstrate broad innate and adaptive leukocyte perturbations that distinguish dysregulated host responses in severe SARS-CoV-2 infection and warrant therapeutic investigation.


Related Papers

No related papers found

Powered by citation graph analysis